Susquehanna lowered the firm’s price target on Genpact (G) to $42 from $50 and keeps a Neutral rating on the shares. The firm said solid Execution, ATS Momentum Continues, Core Questions Remain. Genpact delivered a solid 4Q25, with results modestly ahead of expectations and continued momentum in Advanced Technology Solutions (ATS) offsetting slower growth in the core business.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G:
- Genpact price target lowered to $50 from $53 at Needham
- Genpact: AI-Led Growth, Margin Durability, and Strong 2026 Visibility Support Buy Rating
- Genpact sees FY26 net revenue growth ‘at least’ 7% on reported basis
- Genpact reports Q4 adjusted EPS 97c, consensus 93c
- Genpact raises quarterly dividend 10% to 18.75c per share